Feasibility of canakinumab withdrawal in colchicine-resistant familial Mediterranean fever.
Sign Up to like & getrecommendations! Published in 2023 at "Rheumatology"
DOI: 10.1093/rheumatology/kead128
Abstract: OBJECTIVES There is no consensus on canakinumab treatment tapering and discontinuation strategies in colchicine-resistant familial Mediterranean fever (FMF) patients. In this study, we aimed to establish a treatment management and discontinuation protocol in pediatric FMF… read more here.
Keywords: fmf patients; familial mediterranean; resistant familial; colchicine resistant ... See more keywords
Correspondence on ‘Long-term efficacy and safety of canakinumab in patients with colchicine-resistant familial Mediterranean fever: results from the randomised phase III CLUSTER trial’
Sign Up to like & getrecommendations! Published in 2020 at "Annals of the Rheumatic Diseases"
DOI: 10.1136/annrheumdis-2020-218901
Abstract: We read with great interest the article “Long-term efficacy and safety of canakinumab in patients with colchicine-resistant familial Mediterranean fever: results from the randomised phase III CLUSTER trial” by Ozen et al .1 This article… read more here.
Keywords: resistant familial; familial mediterranean; patients colchicine; mediterranean fever ... See more keywords